The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001372:Aza Compounds / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D003864:Depression, Chemical; D018492:Dopamine Antagonists; D004299:Dopamine beta-Hydroxylase / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010546:Perphenazine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013141:Spiro Compounds / Q000494:pharmacology; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D001372:Aza Compounds; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D010647:Phenyl Ethers; D010880:Piperidines; D011955:Receptors, Drug; D013141:Spiro Compounds; D014149:Tranquilizing Agents; D010643:Phenoxybenzamine; D010868:Pimozide; D014268:Trifluoperazine; D000661:Amphetamine; D004299:Dopamine beta-Hydroxylase; D010546:Perphenazine; D006220:Haloperidol; D004878:Ergotamine; D009638:Norepinephrine